
Evommune, Inc.
Evommune, Inc. (EVMN)
WebsitePrice
Market cap
Next catalystJanuary 2027 — China Phase 1EVO570 — planned Phase 1 clinical development · Trial initiationSEC filing ↗
Cash
Chart & Events
Core Clinical
PreINDP2P3FilingApproved
PreINDP1P3FilingApproved
PreINDP1P3FilingApproved
PreINDP2P3FilingApproved
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
PreINDP2P3FilingApproved
PreINDP1P3FilingApproved
PreINDP2P3FilingApproved
PreINDP1P3FilingApproved